About Inato
Inato operates a global AI-powered platform that unites pharmaceutical sponsors, research sites, and patients to make clinical trials faster, more efficient, and more inclusive. The company addresses critical challenges in clinical research including site selection, patient recruitment, and trial diversity by leveraging artificial intelligence and real-time patient access data. Inato's platform serves over 6,000 research sites across 50+ countries and works with 25+ pharmaceutical sponsors to optimize trial planning, site selection, and patient enrollment. The company's core technology includes AI-powered site selection tools that match sponsors with qualified sites based on actual capabilities and patient access, and AI pre-screening capabilities that automate chart review to identify eligible patients and accelerate enrollment. By reducing site burden and streamlining workflows, Inato helps bring medical breakthroughs to underserved communities and diverse patient populations. The platform has demonstrated measurable impact, with case studies showing enrollment rates exceeding targets by up to 181%, 66% faster enrollment times, and significant improvements in patient diversity. Founded with a mission to create a world where all patients can access the right trials in their community, Inato is backed by global healthcare investors and co-develops its technology with forward-thinking pharmaceutical and site leaders.
Mission & Story
Mission
Create a world where all patients can access the right trials for them in their community, making medical research more accessible, inclusive, and efficient
Founding Story
Founded by Kourosh Davarpanah (CEO), Liz Beatty (Chief Strategy Officer), Jean-David Zeitoun (Chief Medical Officer), and Philippe Ravaud (Chief Scientific Officer) to address the inaccessibility, inefficiency, and lack of representation in clinical trials. The founders recognized that clinical trials have long been inaccessible to many patients and sought to reimagine how research happens by building a platform that empowers sponsors to design more inclusive trials and bring research into more communities globally.
Clinical Focus
Medical conditions and clinical areas addressed by Inato.
Who It Serves
Milestones & Awards
Recent Milestones
Launched AI Site Selection capabilities (September 2025); Partnership with RealTime eClinical Solutions announced (September 2025); Integration with eClinPro Site CTMS (April 2026); Published validation study on multimodal LLM pipeline (November 2025); Won Fast Company's Most Innovative Companies award (2024); Fireside chat with Sanofi at SCOPEX discussing portfolio-level planning (June 2028 - likely typo for 2025)
Awards & Recognition
Fast Company's Most Innovative Companies Of 2024
Key Partnerships
Social & Media
Latest Updates
5 Takeaways From our Fireside Chat with Sanofi
-688d ago
181 Hours and $4,500 Saved: Inside One Weight Loss Trial With Inato
3mo ago
Inato Integrates With eClinPro To Streamline Patient Screening and Enrollment
3mo ago
SCOPE Orlando 2026 Recap: How Data-Driven Sites Can Prove Patient Access to Win Trials and Accelerate Enrollment
5mo ago
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.